Showing results (361-370 of 790) with videos related to
Sort By:
Pageof 79
Blood|May 31, 2013
CD40L expression permits CD8+ T cells to execute immunologic helper functionsMarco Frentsch, Regina Stark, Nadine Matzmohr, et al.Tuberculosis (Edinburgh, Scotland)|April 5, 2011
Polyfunctional Mycobacterium tuberculosis-specific effector memory CD4+ T cells at sites of pleural TBL El Fenniri, Z Toossi, H Aung, et al.Nature Medicine|July 22, 2009
Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cellsNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.Journal of Cardiovascular Electrophysiology|March 20, 2014
Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarinStephen P Page, Neil Herring, Ross J Hunter, et al.Plos Pathogens|July 23, 2013
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasisFernanda O Novais, Lucas P Carvalho, Joel W Graff, et al.Molecular Therapy. Methods & Clinical Development|December 15, 2018
AAV8 Gene Therapy for Crigler-Najjar Syndrome in Macaques Elicited Transgene T Cell Responses That Are Resident to the LiverJenny A Greig, Roberto Calcedo, Leticia Kuri-Cervantes, et al.Blood|June 10, 2009
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cellsFederico Mingozzi, Janneke J Meulenberg, Daniel J Hui, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2003
Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responsesMarc Tritel, Amy M Stoddard, Barbara J Flynn, et al.Scientific Reports|January 14, 2017
Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individualsJohanna Tauriainen, Lydia Scharf, Juliet Frederiksen, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentrationMichael R Betts, David A Price, Jason M Brenchley, et al.Pageof 79